These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ, Rossi AF, Courtney M, Gelb BD. J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [Abstract] [Full Text] [Related]
3. Significance of central perivenulitis in pediatric liver transplantation. Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT. Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942 [Abstract] [Full Text] [Related]
4. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J. Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091 [Abstract] [Full Text] [Related]
5. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, Williams R. Transplantation; 1995 Nov 15; 60(9):1016-23. PubMed ID: 7491675 [Abstract] [Full Text] [Related]
6. ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB). Osorio AV, Sullivan EK, Alexander SR, Bryan CF, Shield CF, Warady BA. Pediatr Transplant; 1998 Feb 15; 2(1):26-9. PubMed ID: 10084756 [Abstract] [Full Text] [Related]
7. Inappropriate expression of blood group antigens in hepatic allografts. Bloom S, Fleming K, Chapman R, Neuberger J, Hubscher S. Hepatology; 1994 Apr 15; 19(4):876-81. PubMed ID: 8138260 [Abstract] [Full Text] [Related]
8. The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Tejani AH, Stablein DM, Sullivan EK, Alexander SR, Fine RN, Harmon WE, Kohaut EC. Pediatr Transplant; 1998 Nov 15; 2(4):318-24. PubMed ID: 10084737 [Abstract] [Full Text] [Related]
9. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H. Hepatology; 1996 Feb 15; 23(2):240-8. PubMed ID: 8591847 [Abstract] [Full Text] [Related]
10. Adult ABO-incompatible liver transplantation, using A and B donors. Skogsberg U, Breimer ME, Friman S, Mjörnstedt L, Mölne J, Olausson M, Rydberg L, Svalander CT, Bäckman L. Xenotransplantation; 2006 Mar 15; 13(2):154-9. PubMed ID: 16623811 [Abstract] [Full Text] [Related]
11. Towards minimizing immunosuppression in pediatric liver transplant recipients. Turmelle YP, Nadler ML, Anderson CD, Doyle MB, Lowell JA, Shepherd RW. Pediatr Transplant; 2009 Aug 15; 13(5):553-9. PubMed ID: 19067920 [Abstract] [Full Text] [Related]
12. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965 [Abstract] [Full Text] [Related]
13. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME. Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581 [Abstract] [Full Text] [Related]
14. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M. Transpl Immunol; 2004 Jul 15; 13(2):139-46. PubMed ID: 15380544 [Abstract] [Full Text] [Related]
15. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation. Matinlauri IH, Höckerstedt KA, Isoniemi HM. Clin Transplant; 2005 Oct 15; 19(5):626-31. PubMed ID: 16146554 [Abstract] [Full Text] [Related]
16. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda. Chinnock R, Emery J, Larsen R, Baum M, Janner D, Razzouk A, Gundry S, Nehlsen-Cannarella S, Bailey L. J Heart Lung Transplant; 1995 Oct 15; 14(4):726-33. PubMed ID: 7578182 [Abstract] [Full Text] [Related]
17. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P. Liver Transpl; 2002 Dec 15; 8(12):1138-46. PubMed ID: 12474153 [Abstract] [Full Text] [Related]
18. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, Stone MJ, Klintmalm G. Transplantation; 1994 Oct 15; 58(7):786-92. PubMed ID: 7940711 [Abstract] [Full Text] [Related]
19. Outcome of ABO-incompatible liver transplantation in children with no specific alloantibodies at the time of transplantation. Yandza T, Lambert T, Alvarez F, Gauthier F, Jacolot D, Huault G, Fabre M, Valayer J. Transplantation; 1994 Jul 15; 58(1):46-50. PubMed ID: 8036707 [Abstract] [Full Text] [Related]
20. Donor age and outcome of liver transplantation. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, Belle SH, Detre KM. Hepatology; 1996 Jul 15; 24(1):89-96. PubMed ID: 8707288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]